Your session is about to expire
← Back to Search
AVP-786 for Schizophrenia
Study Summary
This trial will test a new drug, AVP-786, to see if it can improve negative symptoms of schizophrenia better than a placebo.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 3 trial • 387 Patients • NCT02442765Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many different hospitals are a part of this clinical trial?
"There are a total of 46 clinical research sites taking part in this study. These locations include Miami Lakes, San Bernardino, Doral and 43 other centres."
Are new participants still being accepted into this trial?
"The information available on clinicaltrials.gov supports that this research is ongoing and looking for subjects. The study was originally published on February 15th, 2019 with the most recent update being October 26th, 2022. There are a total of 46 different sites where the trial is recruiting patients from with the goal of finding 370 individuals in total."
Is this research project only enrolling participants who are 18 years of age or older?
"Eligible patients for this clinical trial must be between 18-60 years old. There are 47 other trials recruiting patients who are underaged and 174 that focus on an elderly demographic."
Could I possibly take part in this experiment?
"Eligible participants for this trial must have a diagnosis of schizophrenia and be between 18-60 years old. Currently, the goal is to recruit 370 individuals."
How many individuals are being monitored in this research?
"In order to have statistically significant results, this study requires 370 individuals that meet the pre-specified inclusion criteria. If you are eligible and interested in participating, patients can sign up at Clinical Research Site #840-084 in Miami Lakes or Clinical Research Site# 840-081 in San Bernardino."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger